Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate

Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial complex I and oxidative phosphorylation has been reported to correlate with improved outcomes in head and neck squamous cell carcinoma (HNSCC) and other cancers. This effect is postulated to occur through disruption...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Curry, Joseph M., Johnson, Jennifer, Mollaee, Mehri, Tassone, Patrick, Amin, Dev, Knops, Alexander, Whitaker-Menezes, Diana, Mahoney, My G., South, Andrew, Rodeck, Ulrich, Zhan, Tingting, Harshyne, Larry, Philp, Nancy, Luginbuhl, Adam, Cognetti, David, Tuluc, Madalina, Martinez-Outschoorn, Ubaldo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6193523/
https://ncbi.nlm.nih.gov/pubmed/30364350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00436
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller